Analysts Estimate Innospec (IOSP) to Report a Decline in Earnings: What to Look Out for

Company Overview - Innospec (IOSP) is expected to report a year-over-year decline in earnings, with a projected EPS of $1.36, reflecting a decrease of 26.1$450.75 million, down 8.9% from the same quarter last year [3] Earnings Expectations - The earnings report is scheduled for release on February 18, 2025, and the actual results will significantly influence the stock price depending on whether they meet or exceed expectations [2] - The consensus EPS estimate has been revised 0.74% lower in the last 30 days, indicating a reassessment by analysts [4] Earnings Surprise Prediction - The Most Accurate Estimate for Innospec is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +0.37% [10][11] - However, the stock holds a Zacks Rank of 4, which complicates the prediction of an earnings beat [11] Historical Performance - Innospec has matched consensus EPS estimates in the last reported quarter, with no surprise [12] - Over the past four quarters, the company has beaten consensus EPS estimates three times [13] Industry Comparison - Huntsman (HUN), another player in the Zacks Chemical - Diversified industry, is expected to report a loss of $0.12 per share, indicating a year-over-year change of +42.9$1.46 billion, up 4.2% from the previous year [17] - The consensus EPS estimate for Huntsman has been revised down by 95.1% in the last 30 days, but it currently has an Earnings ESP of 7.72%, suggesting a likely earnings beat [18]